1. Get more info on this report!
Glucose Testing Markets
November 1, 2008
This report takes a bold look into the world glucose testing, ten years from now. It is not
an exercise in crystal ball gazing. Rather, in this report, Kalorama offers a calculated
look into the future, based on events taking place in the present.
The report offers a quantitative assessment of specific markets, worldwide, in US
dollars for 2007 to 2012.
With the reported growing epidemic of diabetes, worldwide, it is widely held that glucose
self testing and diabetes management are among the fastest growing areas in health
care.
compiled from various Kalorama reports including Kalorama's Glucose Testing, The
Worldwide Market for Diagnostic Tests, 6th Edition, and Diabetes and Diabetic
Complications, 2nd edition, A comprehensive look at the world glucose monitoring
market, this survey includes:
Markets and Forecasts for POC Self-Testing By Region(U.S., Asia, Europe, Rest
of World)
World Market and Forecasted Market for Professional Glucose Testing
Diabetes Epidemology for Major Countries
Review of Innovative Glucose Monitoring Products
Market Share
Company Profiles
Predictions on the Future of Glucose Monitoring Products.
As with all Kalorama Information reports, this study is the result of exhaustive research
and interviews with experts in the diagnostic industry. Shara Rosen is the author of
Kalorama's best-selling Worldwide Market for In Vitro Diagnostic Testing, 6th Edition, a
resource used by most major diagnostic companies in decision making and market
estimates.

2. TABLE OF CONTENTS
CHAPTER ONE: EXECUTIVE SUMMARY
Scope and Objectives
Methodology of Investigation
Limitations of the research
A Word About Diabetes
Markets
Professional and POC Glucose Testing
Glucose Self-Testing
CHAPTER TWO: INTRODUCTION
Background
The Pathology of Diabetes and Its Complications
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Epidemiology
Diabetes in UK, U.S., Spain, Germany, Italy, France, Japan and U.S.
CHAPTER THREE: GLUCOSE MONITORING MARKETS
Total Market
Professional Glucose Testing
Glucose Self-Testing
Non-Invasive Products
Innovative Glucose Monitoring Products
CHAPTER FOUR: COMPANY PROFILES
MAJOR COMPETITORS
o Bayer Diabetes Care
o Roche Diagnostics
o Abbott Diagnostics
o Lifescan Inc.
COMPANIES TO WATCH
o 77 Elektronika Kft.
o AgaMatrix, Inc.
o Agilent Technologies Inc.
o Alere Medical Inc.
o ARKRAY
o BIOSAFE Medical Technologies, Inc.
o Biosign Technologies Inc.
o BodyTel Scientific Inc.

3. o DexCom, Inc.
o Diabetech, LP
o GlucoLight Corporation
o GlucoStats System
o GlucoTec, Inc.
o HealthPia America
o Heidelberger-Medical-Marketing GmbH (HMM GmbH)
o HemoCue AB
o Integrity Applications Ltd.
o Luminous Medical, Inc.
o Medtronic Inc.
o A. Menarini Diagnostics
o Menssana Research, Inc.
o OrSense Ltd.
o Oxonica Healthcare
o Philips Medical Systems
o Quadraspec
o Quotient Diagnostics
o RainDance Technologies, Inc. (RDT)
o Roche Diagnostics
TABLE OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
Figure 1-1 World Market for Glucose Testing
Table 1-1: Glucose Monitoring Self-Testing Sales 2007-2012
Figure 1-2: Glucose Monitoring Self-Testing Sales 2007-2012
CHAPTER TWO: INTRODUCTION
Table 2-1: Characteristics of Type I and Type II Diabetes Mellitus
Table 2-2: Common Symptoms and Conditions of Diabetes Mellitus
Table 2-4: Populations of Each of the Seven Major World Healthcare Markets by
Age Group (0-14, 15-64, 65+ Years) 2006
Table 2-5: Prevalence Rates and Cases for Diabetes Mellitus by Type (Type I vs
Type II) in Seven Major World Healthcare Markets 2006
Table 2-6: Prevalence of Diabetes in Seven Major World Healthcare Markets by
Type (I vs II) 2004-2016
Figure 2-1: Trending in the Total Prevalence of Diabetes Cases and the General
Population in the Seven Major World Healthcare Markets 2006 - 2016
Figure 2-2: Composition of the Diabetes Patient Population in the Seven Major
World Healthcare Markets 2006-2016
Figure 2-3: Geographic Distribution of the Total Diabetes Patient Population:
2006 and 2016

4. Figure 2-4: Geographic Distribution of the Type 1 Diabetes Patient Population
2006 and 2016
Figure 2-5: Geographic Distribution of the Type 2 Diabetes Patient Population
2006 and 2016
Figure 2-6: Population Trends in Seven Major World Healthcare Markets: 2006-
2016
CHAPTER THREE: GLUCOSE MONITORING MARKETS
Table 3-1: Glucose Monitoring Self-Testing Sales by Region (US, Europe, Asia,
ROW)
Table 3-2: Glucose Monitoring Self-Testing (OTC) Sales by Region (US, Europe,
Asia, ROW)
Table 3-3: Estimated World Glucose Monitoring Sales by Company 2005-2007
Table 3-4: Selected Blood Glucose Test Devices Innovations, 2006-2007
Figure 3-5: Technology Market Penetration Forecast for New Device Users 2007
- 2020
Available immediately for Online Download at
http://www.marketresearch.com/product/display.asp?productid=1911068
US: 800.298.5699
UK +44.207.256.3920
Int'l: +1.240.747.3093
Fax: 240.747.3004